OCC 0.00% 36.0¢ orthocell limited

Wonder if last quarter was an outlier given it smashed analyst...

  1. 373 Posts.
    lightbulb Created with Sketch. 304
    Wonder if last quarter was an outlier given it smashed analyst growth projections and this result brings it more in line with their expectations? Also wondering if we're getting bulk orders and it's not quarterly, so although we're getting new regions and therefore new customers, we haven't seen the receipts build on last quarter from returning customers yet?

    I don't think any of us were anticipating a flat quarter, I'm not looking to make excuses for the result either. Just considering possibilities for how this outcome has occurred when within the quarterly they're saying Striate is now available globally and being advertised in Europe by another BH subsidiary, the launch of the secondary label PerFORM is supposedly going well, and Remplir sales are building momentum in Aus. Their comments don't add up compared to the figures.
    Last edited by JonesingPanda: 29/01/24
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
36.0¢
Change
0.000(0.00%)
Mkt cap ! $75.35M
Open High Low Value Volume
36.0¢ 36.0¢ 36.0¢ $7.32K 20.33K

Buyers (Bids)

No. Vol. Price($)
5 96140 35.0¢
 

Sellers (Offers)

Price($) Vol. No.
36.0¢ 35294 3
View Market Depth
Last trade - 16.10pm 07/06/2024 (20 minute delay) ?
Last
35.5¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
36.0¢ 36.0¢ 35.5¢ 30431
Last updated 15.59pm 07/06/2024 ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.